New quit smoking course

Guild Learning and Development is partnering with Pfizer in an online course titled “Engage your customers to successfully cease smoking”

This course examines the key barriers to smoking cessation and compares the efficacy and safety of the pharmacological and non-pharmacological therapies that are available to treat nicotine dependence.

The course also outlines the key elements to successful implementation of a pharmacy-led smoking cessation service based on the findings of a two-year smoking cessation trial run in the ACT.

According to the World Health Organization, tobacco smoking accounts for the highest burden of disease of any modifiable risk factor.

Although tobacco smoking levels in Australia have declined in the wake of multiple public health campaigns, more than 15,000 deaths occur annually in Australia due to tobacco smoking.

There are a number of therapies available to assist patients with smoking cessation.

In addition to being able to counsel patients regarding these therapies, pharmacists are well-positioned to assist their patients with other aspects of the quitting process including motivational support, ensuring compliance with pharmacotherapy and recognising where referral for prescription medication is appropriate. 


Community pharmacist, ACT Pharmacy Guild Branch President and Guild National Councillor Amanda Galbraith, said the program run by the ACT Branch, and this online course, clearly demonstrated the important role that community pharmacy played in assisting our patients to successfully quit.

“Counselling, the provision of medicines, and support from a pharmacist, can assist patients to successfully stop smoking and achieve better health outcomes,” she said.

This activity has been accredited for 1.5 hours of Group 1 CPD (or 1.5 CPD credits), suitable for inclusion in an individual pharmacist’s CPD plan, which can be converted to 1.5 hours of Group 2 CPD (or 3 CPD credits) upon successful completion of relevant assessment activities. 

To enrol in this course pharmacists can visit or  contact Guild Learning and Development on 03 9810 9930 or email for more information.

Guild Learning and Development has thanked Pfizer for its financial support and input of expertise in the development of this course. 

Previous New professional responsibilities resource
Next No risk factors in quarter of heart attacks

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.

No Comment

Leave a reply